SCHEMBL3813067

SCHEMBL3813067

CS(=O)(=O)Nc1ccc(Cn2cc(I)c3c(N)ncnc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 4/20 0.48
▸ PIK3CD O00329 4/20 0.48
▸ KDR P35968 3/20 0.48
▸ ABL1 P00519 2/20 0.48
▸ EGFR P00533 2/20 0.48
▸ HCK P08631 2/20 0.48
▸ PIK3CA P42336 2/20 0.48
▸ MTOR P42345 2/20 0.48
▸ PIK3CG P48736 2/20 0.48
▸ EPHB4 P54760 2/20 0.48
▸ PRKDC P78527 2/20 0.48
▸ PI4KB Q9UBF8 2/20 0.48
▸ FLT3 P36888 2/20 0.44
▸ DYRK3 O43781 1/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ PHKG2 P15735 1/20 0.44
▸ PRKACA P17612 1/20 0.44
▸ RPS6KB1 P23443 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3811612 0.81 DYRK3 (0.56) SRCKDRABL1EGFRMTOR
SCHEMBL16236686 0.77 DYRK3 (0.52) SRCHCKMTORPI4KBFLT3
SCHEMBL3817538 0.76 SLC29A1 (0.47) PIK3CDPIK3CAPIK3CGPRKDCFLT3
SCHEMBL3819444 0.76 FLT3 (0.47) SRCKDRABL1EGFRFLT3
SCHEMBL16236417 0.72 DYRK3 (0.58) SRCPIK3CDABL1EGFRPIK3CA
SCHEMBL3782622 0.71 DYRK3 (0.59) MTORPI4KBFLT3DYRK3ROCK2
SCHEMBL29503447 0.71 DYRK3 (0.59) MTORPI4KBFLT3DYRK3ROCK2
SCHEMBL16236697 0.71 DYRK3 (0.48) SRCPIK3CDKDRABL1EGFR
SCHEMBL19779801 0.70 KLKB1 (0.47) KDRMTORPI4KBFLT3DYRK3
SCHEMBL23885307 0.69 DYRK3 (0.58) SRCEGFRMTORFLT3DYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730148-A4 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LAB (US) 2009-08-19 — — EP disclosed
EP-1730148-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS Abbott Laboratories (US) 2006-12-13 — — EP disclosed
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABBOTT LABORATORIES 2006-02-02 — — US disclosed
WO-2005074603-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2005-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABL1, MAP3K19, MAP3K20 SRC 116/4885PIK3CD 146/4885KDR 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback